惠雲鈦業(300891.SZ):年產3萬噸鋭鈦型鈦白粉技改項目(二期)驗收
格隆匯1月5日丨惠雲鈦業(300891.SZ)公佈,公司的自有資金投資建設“年產3萬噸鋭鈦型鈦白粉技改項目(二期)”已於近日完成環保自主驗收及公示,項目達產後,公司鋭鈦型生產線將形成3萬噸/年的鋭鈦型鈦白粉生產能力。
該項目建設完成後,有利於實現公司擴能增效,隨着公司產能規模的擴大,規模效應逐漸體現,是公司完善產業佈局、進一步夯實核心競爭力及拓展行業市場的重要舉措。
該項目符合國家相關的產業政策以及未來公司整體戰略發展方向,有利於進一步擴大公司的業務規模,提升公司的行業地位和抗風險能力,增強公司綜合實力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.